Bayer HealthCare Injects $25 Million Into New Versant Ventures Biotech, Device Fund

Bayer HealthCare will invest $25 million in a new Versant Ventures fund for biotech and medical device companies.

Bayer and Versant did not say how large the fund ultimately will be or list the fund’s other limited partners.

It isn’t the first time that a Big Pharma player — or Bayer itself — has crossed paths with San Francisco’s Versant.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC